marginally significantP=0.056
Of those who had not received depot neuroleptics, it was offered to 20% of the psychosis and 7% of the non-psychosis patients which was marginally significant (χ 2 (2)=5.75, P=0.056).
Of those who had not received depot neuroleptics, it was offered to 20% of the psychosis and 7% of the non-psychosis patients which was marginally significant (χ 2 (2)=5.75, P=0.056).